Evidence map›Paper›PMID 32457198›Full record

ArticleThe European respiratory journal2020

Active tuberculosis, sequelae and COVID-19 co-infection: first cohort of 49 cases.

Marina Tadolini, Luigi Ruffo Codecasa, José-María García-García, François-Xavier Blanc, Sergey Borisov, Jan-Willem Alffenaar, Claire Andréjak, Pierre Bachez, Pierre-Alexandre Bart, Evgeny Belilovski and 36 more

Abstract readLetter
In one paragraph

Article in The European respiratory journal, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 236 papers, 7 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
236citing papers in PubMed, 7 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

236 citing papers in PubMed, 7 syntheses or guidelines pooled it.

  1. Delamanid-containing regimens and multidrug-resistant tuberculosis: A systematic review and meta-analysis.International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases · 2022
    Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pathology of TB/COVID-19 Co-Infection: The phantom menace.Tuberculosis (Edinburgh, Scotland) · 2021
    Pooled it
  7. Pooled it
  8. Trial
  9. Trial
  10. Article
  11. Review
  12. Crosstalk betweenFrontiers in immunology · 2026
    Article
  13. Review
  14. Article
  15. Promising Prodiginins Biological Activities.Chemistry & biodiversity · 2025
    Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

176 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

46 authors.

Marina TadoliniUnit of Infectious Diseases, Dept of Medical and Surgical Sciences, Alma Mater Studiorum University of Bologna, Bologna, Italy.
Luigi Ruffo CodecasaTB Reference Centre, Villa Marelli Institute, Niguarda Hospital, Milan, Italy.
José-María García-GarcíaTuberculosis Research Programme (PII-TB), SEPAR, Barcelona, Spain.ORCID 0000-0002-2809-6230
François-Xavier BlancCentre Hospitalier Universitaire, Nantes, France.ORCID 0000-0001-7644-2188
Sergey BorisovMoscow Research and Clinical Center for TB Control, Moscow, Russian Federation.
Jan-Willem AlffenaarThe University of Sydney, Sydney Pharmacy School, Sydney, Australia.
Claire AndréjakService de Pneumologie CHU AMIENS PICARDIE, France AND UR Université de Picardie Jules Verne, Amiens, France.
Pierre BachezService de Pneumologie, Clinique Saint Luc, Bouge, Belgium.
Pierre-Alexandre BartDept of Internal Medicine, Lausanne University, Lausanne, Switzerland.
Evgeny BelilovskiMoscow Research and Clinical Center for TB Control, Moscow, Russian Federation.
José Cardoso-LandivarServicio Neumología, Vall D´Hebron University Hospital, Barcelona, Spain.
Rosella CentisServizio di Epidemiologia Clinica delle Malattie Respiratorie, Istituti Clinici Scientifici Maugeri IRCCS, Tradate, Italy.ORCID 0000-0002-8551-3598
Lia D'AmbrosioPublic Health Consulting Group, Lugano, Switzerland.ORCID 0000-0002-7000-5777
María- Luiza De Souza-GalvãoServicio Neumología, Vall D´Hebron University Hospital, Barcelona, Spain.ORCID 0000-0001-9703-989X
Angel Dominguez-CastellanoServicio de Enfermedades Infecciosas y Microbiología, Hospital Virgen Macarena, Sevilla, Spain.
Samir DourmaneService de Pneumologie, Groupe hospitalier sud île de France (GHSIF), Melun, France.
Mathilde Fréchet JachymCentre Hospitalier de Bligny, Briis Sous Forges, France.
Antoine FroissartService de Médecine interne, CHI de Créteil, Créteil, France.
Vania GiacometPediatric Infectious Diseases Unit, Dept of Biomedical and Clinical Sciences, L. Sacco Hospital, University of Milan, Milan, Italy.
Delia GolettiTranslational Research Unit, National Institute for Infectious Diseases 'L. Spallanzani', IRCCS, Rome, Italy.
Soazic GrardCentre de Lutte Antituberculeuse (CLAT 38), Grenoble, France.
Gina GualanoRespiratory Infectious Diseases Unit, National Institute for Infectious Diseases 'L. Spallanzani', IRCCS, Rome, Italy.
Armine IzadifarHôpital Européen de Paris La Roseraie, Aubervilliers, France.
Damien Le DuCentre Hospitalier de Bligny, Briis Sous Forges, France.
Margarita Marín RoyoServicio Neumología, Hospital General Universitario de Castellón, Castelló, Spain.
Jesica Mazza-StalderPulmonary Division, Lausanne University Hospital CHUV, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland.
Ilaria MottaDipartimento di Scienze Mediche, Clinica Universitaria Malattie Infettive, Ospedale Amedeo di Savoia, Torino, Italia.
Catherine Wei Min OngDept of Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore.
Fabrizio PalmieriRespiratory Infectious Diseases Unit, National Institute for Infectious Diseases 'L. Spallanzani', IRCCS, Rome, Italy.ORCID 0000-0001-8184-6291
Frédéric RivièreHôpital d'Instruction des Armées (HIA) Percy, Clamart, France.
Teresa RodrigoTuberculosis Research Programme (PII-TB), SEPAR, Barcelona, Spain.ORCID 0000-0003-3663-5828
Denise Rossato SilvaFaculdade de Medicina, Universidade Federal do Rio Grande do Sul - UFRGS, Porto Alegre, Brazil.
Adrián Sánchez-MontalváInfectious Diseases Dept, International Health and Tuberculosis Unit, Vall d'Hebron University Hospital, Barcelona, Spain.
Matteo SaporitiTB Reference Centre, Villa Marelli Institute, Niguarda Hospital, Milan, Italy.
Paolo ScarpelliniUnit of Infectious Diseases, Università Vita e Salute, San Raffaele Hospital, Milan, Italy.ORCID 0000-0003-3136-2488
Frédéric SchlemmerHôpitaux Universitaires Henri Mondor, AP-HP, Créteil, France.ORCID 0000-0003-2113-7113
Antonio SpanevelloDivision of Pulmonary Rehabilitation, Istituti Clinici Scientifici Maugeri, IRCCS, Tradate, Italy.
Elena SumarokovaMoscow Research and Clinical Center for TB Control, Moscow, Russian Federation.
Eva TaberneroServicio Neumología, Hospital de Cruces, Bilbao, Spain.
Paul Anantharajah TambyahDept of Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore.
Simon TiberiBlizard Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK.ORCID 0000-0002-0738-4276
Alessandro TorreDept of Infectious Diseases, University of Milan, L. Sacco Hospital, Milan, Italy.
Dina ViscaDivision of Pulmonary Rehabilitation, Istituti Clinici Scientifici Maugeri, IRCCS, Tradate, Italy.ORCID 0000-0003-2298-1623
Miguel Zabaleta MurguiondoServicio Neumología Hospital Universitario Marqués de Valdecilla, Santander, Spain.
Giovanni SotgiuClinical Epidemiology and Medical Statistics Unit, Dept of Medical, Surgical and Experimental Sciences, University of Sassari, Sassari, Italy.ORCID 0000-0002-1600-4474
Giovanni Battista MiglioriServizio di Epidemiologia Clinica delle Malattie Respiratorie, Istituti Clinici Scientifici Maugeri IRCCS, Tradate, Italy giovannibattista.migliori@icsmaugeri.it.ORCID 0000-0002-2597-574X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AdultAgedAntitubercular AgentsAntiviral AgentsAzithromycinBetacoronavirusClinical Laboratory TechniquesCohort StudiesCoinfectionCoronavirus InfectionsCOVID-19COVID-19 Drug TreatmentCOVID-19 TestingDrug CombinationsEmigrants and ImmigrantsFemaleAntitubercular AgentsAntiviral AgentsAzithromycinDrug CombinationsHydroxychloroquineLopinavirlopinavir-ritonavir drug combinationRitonavir

Identifiers

PMID32457198
PMCPMC7251245

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.